R6 Ballot (3rd Draft) FHIR CI-Build

Publish-box (todo) This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example MedicationRequest/medrx0317 (Narrative)

Maturity Level : N/A
Responsible Owner: Pharmacy Work Group Standards Status : Informative Compartments : Encounter , Group , Patient , Practitioner

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationRequest .

Generated Narrative: MedicationRequest medrx0317

identifier : http://www.bmc.nl/portal/prescriptions /12345689 (use: official, )

status : completed Completed

intent : order Order

Medications

- Reference
* Medication alemtuzumab 10 MG/ML [Lemtrada]

subject : Donald Duck

authoredOn : 2015-01-15

requester : Patrick Pump

Reasons

- Concept
* Chronic lymphoid leukemia, disease (disorder)

dosageInstruction

sequence : 1

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated , Administer on alternate days

timing : Duration 12weeks , 3 per 1 week

route : Intravenous route

method : Inject - dosing instruction imperative (qualifier value)

DoseAndRates

- Type Dose[x]
* Ordered 3 mg (Details: UCUM codemg = 'mg')

dosageInstruction

sequence : 2

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated , Administer on alternate days

timing : Duration 12weeks , 3 per 1 week

route : Intravenous route

method : Inject - dosing instruction imperative (qualifier value)

DoseAndRates

- Type Dose[x]
* Ordered 10 mg (Details: UCUM codemg = 'mg')

dosageInstruction

sequence : 3

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated , Administer on alternate days

timing : Duration 12weeks , 3 per 1 week

route : Intravenous route

method : Inject - dosing instruction imperative (qualifier value)

DoseAndRates

- Type Dose[x]
* Ordered 30 mg (Details: UCUM codemg = 'mg')

Generated Narrative: Medication #med0303

code : alemtuzumab 10 MG/ML [Lemtrada]

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.